CANCER CONTROL 潤色咨詢

Cancer Control

出版年份:暫無數(shù)據(jù) 年文章數(shù):976 投稿命中率: 開通期刊會員,數(shù)據(jù)隨心看

出版周期:Quarterly 自引率:0.4% 審稿周期: 開通期刊會員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費用
暫無數(shù)據(jù)
版面費用
暫無數(shù)據(jù)
中國人發(fā)表比例
2023年中國人文章占該期刊總數(shù)量37.76% (2022年為44.16%)
自引率
0.4 %
年文章數(shù)
976
期刊官網(wǎng)
點擊查看 (點擊次數(shù):8826)
投稿鏈接
點擊查看 (點擊次數(shù):6024次)
作者需知
點擊查看 (點擊次數(shù):1607次)
期刊簡介
稿件收錄要求

Cancer Control is a JCR-ranked open access journal whose mission is to advance the prevention, detection, diagnosis, treatment, and palliative care of cancer by enabling researchers, doctors, policymakers, and other healthcare professionals to freely share research along the cancer control continuum. Our vision is a world where gold-standard cancer care is the norm, not the exception.
The journal is organized into five topical sections, as well as a sixth curated by members of the Moffitt Cancer Center. The topical sections are inspired by the foci of the cancer control continuum (prevention, detection, diagnosis, treatment, survivorship).

Article Types and Topics of Interest
Cancer Control welcomes original research (clinical studies), reviews, and commentaries. We encourage submissions relating to advances in the following areas:

  • Communications in cancer research
  • Surveillance
  • Social Determinants of Health Disparities
  • Genetic Testing
  • Decision-Making
  • Dissemination of Evidence-Based Interventions
  • Health Care Delivery and Quality of Care
  • Epidemiology
  • Measurement

View a selection of the latest papers published in Cancer Control.

Journal Highlights

  • Impact Factor of 1.990
  • Published at SAGE since 2017
  • Article Processing Charge of $2200 USD
  • Focus on prevention, detection, diagnosis, treatment, and palliative care of cancer
  • Fast and double-blind peer review by dedicated Associate Editors and Editorial Board Members

Cancer Control is a JCR-ranked, peer-reviewed open access journal whose mission is to advance the prevention, detection, diagnosis, treatment, and palliative care of cancer by enabling researchers, doctors, policymakers, and other healthcare professionals to freely share research along the cancer control continuum. Please see the Aims and Scope tab for further information.